MediWound (MDWD) EV to EBIT (2014 - 2026)
MediWound (MDWD) posted EV to EBIT of 16.21 for Q2 2026, up 32.41% on a QoQ basis from 23.99 in Q1 2026, and up 47.53% year-over-year from 10.99 in Q2 2025.
Powered by 
Analysis
MediWound (MDWD) EV to EBIT (2014 - 2026) Analysis & Trends
MediWound has reported EV to EBIT for 13 years, with the latest figure at 16.21 in Q2 2026.
- On a quarterly basis, EV to EBIT rose 47.53% year-over-year to 16.21 in Q2 2026; TTM through Jun 2026 was 4.83, a 39.53% increase from a year earlier, with the FY2025 full-year figure at 7.27, up 5.26% from the prior year.
- EV to EBIT was 16.21 for Q2 2026 at MediWound, up from 23.99 in the prior quarter.
- The five-year high for EV to EBIT was 15.72 in Q4 2022, with the low at 33.94 in Q1 2024.
- Average EV to EBIT over 5 years is 15.32, with a median of 18.48 recorded in 2025.
- The sharpest annual moves came in 2023 and 2024: EV to EBIT jumped 263.93% in 2023, then plunged 4889.31% in 2024.
- Over 5 years, EV to EBIT stood at 15.72 in 2022, then plunged by 185.06% to 13.37 in 2023, then plunged by 82.56% to 24.41 in 2024, then rose by 3.49% to 23.56 in 2025, then surged by 31.2% to 16.21 in 2026.
- The last three EV to EBIT figures came in at 16.21 (Q2 2026), 23.99 (Q1 2026), and 23.56 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | MediWound | 156.09 Mn | 120.75 Mn | 337,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -16.21 |
| Mar 31, 2026 | -23.99 |
| Dec 31, 2025 | -23.56 |
| Sep 30, 2025 | -20.75 |
| Jun 30, 2025 | -30.90 |
| Mar 31, 2025 | -31.80 |
| Dec 31, 2024 | -24.41 |
| Sep 30, 2024 | -23.81 |
| Jun 30, 2024 | -25.40 |
| Mar 31, 2024 | -33.94 |
| Dec 31, 2023 | -13.37 |
| Sep 30, 2023 | 9.49 |
| Jun 30, 2023 | -0.51 |
| Mar 31, 2023 | -2.11 |
| Dec 31, 2022 | 15.72 |
| Sep 30, 2022 | -5.79 |
| Jun 30, 2022 | -12.93 |
| Mar 31, 2022 | -11.46 |
| Dec 31, 2021 | -15.14 |
| Sep 30, 2021 | -31.48 |